175 related articles for article (PubMed ID: 29987823)
1. Rat Model of Cardiotoxic Drug-Induced Cardiomyopathy.
Nakahara T; Tanimoto T; Petrov AD; Ishikawa K; Strauss HW; Narula J
Methods Mol Biol; 2018; 1816():221-232. PubMed ID: 29987823
[TBL] [Abstract][Full Text] [Related]
2. Short-term and long-term models of doxorubicin-induced cardiomyopathy in rats: A comparison of functional and histopathological changes.
O'Connell JL; Romano MM; Campos Pulici EC; Carvalho EE; de Souza FR; Tanaka DM; Maciel BC; Salgado HC; Fazan-Júnior R; Rossi MA; Simões MV
Exp Toxicol Pathol; 2017 Apr; 69(4):213-219. PubMed ID: 28153388
[TBL] [Abstract][Full Text] [Related]
3. Heart rate dynamics in doxorubicin-induced cardiomyopathy.
Lončar-Turukalo T; Vasić M; Tasić T; Mijatović G; Glumac S; Bajić D; Japunžić-Žigon N
Physiol Meas; 2015 Apr; 36(4):727-39. PubMed ID: 25798626
[TBL] [Abstract][Full Text] [Related]
4. Long-lasting effect of dexrazoxane against anthracycline cardiotoxicity in rats.
Della Torre P; Podesta A; Pinciroli G; Iatropoulos MJ; Mazué G
Toxicol Pathol; 1996; 24(4):398-402. PubMed ID: 8864181
[TBL] [Abstract][Full Text] [Related]
5. An integrated characterization of serological, pathological, and functional events in doxorubicin-induced cardiotoxicity.
Cove-Smith L; Woodhouse N; Hargreaves A; Kirk J; Smith S; Price SA; Galvin M; Betts CJ; Brocklehurst S; Backen A; Radford J; Linton K; Roberts RA; Schmitt M; Dive C; Tugwood JD; Hockings PD; Mellor HR
Toxicol Sci; 2014 Jul; 140(1):3-15. PubMed ID: 24675088
[TBL] [Abstract][Full Text] [Related]
6. Validation of the use of long-term indwelling jugular catheters in a rat model of cardiotoxicity.
Wachtman LM; Browning MD; Bedja D; Pin S; Gabrielson KL
J Am Assoc Lab Anim Sci; 2006 Sep; 45(5):55-64. PubMed ID: 16995648
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin mediated cardiotoxicity in rats: protective role of felodipine on cardiac indices.
Gandhi H; Patel VB; Mistry N; Patni N; Nandania J; Balaraman R
Environ Toxicol Pharmacol; 2013 Nov; 36(3):787-95. PubMed ID: 23958971
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular variability and β-ARs gene expression at two stages of doxorubicin - Induced cardiomyopathy.
Vasić M; Lončar-Turukalo T; Tasić T; Matić M; Glumac S; Bajić D; Popović B; Japundžić-Žigon N
Toxicol Appl Pharmacol; 2019 Jan; 362():43-51. PubMed ID: 30342983
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of taurine against doxorubicin-induced cardiotoxicity in rats: echocardiographical and histological findings.
Barış VÖ; Gedikli E; Yersal N; Müftüoğlu S; Erdem A
Amino Acids; 2019 Nov; 51(10-12):1649-1655. PubMed ID: 31673792
[TBL] [Abstract][Full Text] [Related]
10. Metabonomic study on the cumulative cardiotoxicity of a pirarubicin liposome powder.
Cong W; Liang Q; Li L; Shi J; Liu Q; Feng Y; Wang Y; Luo G
Talanta; 2012 Jan; 89():91-8. PubMed ID: 22284464
[TBL] [Abstract][Full Text] [Related]
11. Hyperbaric oxygen therapy does not potentiate doxorubicin-induced cardiotoxicity in rats.
Karagoz B; Suleymanoglu S; Uzun G; Bilgi O; Aydinoz S; Haholu A; Turken O; Onem Y; Kandemir EG
Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):287-92. PubMed ID: 18248515
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin cardiotoxicity in the rat: an in vivo characterization.
Hayward R; Hydock DS
J Am Assoc Lab Anim Sci; 2007 Jul; 46(4):20-32. PubMed ID: 17645292
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC
Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin cardiotoxicity: diastolic cardiac myocyte dysfunction as a result of impaired calcium handling in isolated cardiac myocytes.
Maeda A; Honda M; Kuramochi T; Takabatake T
Jpn Circ J; 1998 Jul; 62(7):505-11. PubMed ID: 9707007
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.
Takemura G; Fujiwara H
Prog Cardiovasc Dis; 2007; 49(5):330-52. PubMed ID: 17329180
[TBL] [Abstract][Full Text] [Related]
16. Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.
Potočnik N; Perše M; Cerar A; Injac R; Finderle Ž
PLoS One; 2017; 12(7):e0181632. PubMed ID: 28727839
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural and Echocardiographic Assessment of Chronic Doxorubicin-Induced Cardiotoxicity in Rats.
Babaei H; Razmaraii N; Assadnassab G; Mohajjel Nayebi A; Azarmi Y; Mohammadnejad D; Azami A
Arch Razi Inst; 2020 Mar; 75(1):55-62. PubMed ID: 32292003
[TBL] [Abstract][Full Text] [Related]
18. [A case of irreversible cardiomyopathy induced by polychemotherapy].
Skopets IS; Vezikova NN; Ivanova EP; Sergeeva SS; Ignatenko OV
Ter Arkh; 2015; 87(12):73-76. PubMed ID: 26978422
[TBL] [Abstract][Full Text] [Related]
19. Overweight in mice, induced by perinatal programming, exacerbates doxorubicin and trastuzumab cardiotoxicity.
Guenancia C; Hachet O; Aboutabl M; Li N; Rigal E; Cottin Y; Rochette L; Vergely C
Cancer Chemother Pharmacol; 2016 Apr; 77(4):777-85. PubMed ID: 26914236
[TBL] [Abstract][Full Text] [Related]
20. The protective effect of melatonin on adriamycin-induced acute cardiac injury.
Koçak G; Erbil KM; Ozdemir I; Aydemir S; Sunar B; Tuncel M; Atalay S
Can J Cardiol; 2003 Apr; 19(5):535-41. PubMed ID: 12717489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
